Please assess the completion status of the following clinical trial:

Trial Title: Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Major depressive disorder~* Use of an SSRI for at least 6 weeks prior to study entry with partial or no response~Exclusion Criteria:~* History of psychosis~* Allergy to SAMe~* Alcohol or drug abuse in the past 3 months prior to study entry

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 1 Oral SAMe Tosylate (Type: EXPERIMENTAL): Participants receiving the oral SAMe tosylate
- 2 Oral Placebo Pill Twice Daily (Type: PLACEBO_COMPARATOR): Participants receiving placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).